<DOC>
	<DOC>NCT01097811</DOC>
	<brief_summary>Comparison between the efficacy of two different antibiotics in patients with overt hepatic encephalopathy. The study is randomized, controlled and double-blinded.</brief_summary>
	<brief_title>Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Hypertension, Portal</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<criteria>Hepatic cirrhosis or portal hypertension Hepatic Encephalopathy Acute liver failure Neuropsychiatric diseases Inflammatory bowel diseases Intestinal obstruction Shock Renal insufficiency Alcoholic hepatitis Alcohol abuse Antibiotic premedication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Hepatic Encephalopathy</keyword>
	<keyword>Hypertension, Portal</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Bacterial Overgrowth Syndrome</keyword>
</DOC>